The AI Factor: Why Cash Still Flows To European Biotech Startups
Despite concerns about startup investment overall, Biotech continues to attract VC capital. The combination of AI and biology is accelerating new treatment development
Despite concerns about startup investment overall, Biotech continues to attract VC capital. The combination of AI and biology is accelerating new treatment development